{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T12:45:09Z","timestamp":1754484309318,"version":"3.41.2"},"reference-count":157,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T00:00:00Z","timestamp":1650499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Heart transplantation remains the optimal treatment option for patients with end-stage heart disease. Growing evidence demonstrates that purinergic signals mediated by purine nucleotides and nucleosides play vital roles in heart transplantation, especially in the era of ischemia-reperfusion injury (IRI) and allograft rejection. Purinergic signaling consists of extracellular nucleotides and nucleosides, ecto-enzymes, and cell surface receptors; it participates in the regulation of many physiological and pathological processes. During transplantation, excess adenosine triphosphate (ATP) levels are released from damaged cells, and driver detrimental inflammatory responses largely<jats:italic>via<\/jats:italic>purinergic P2 receptors. Ecto-nucleosidases sequentially dephosphorylate extracellular ATP to ADP, AMP, and finally adenosine. Adenosine exerts a cardioprotective effect by its anti-inflammatory, antiplatelet, and vasodilation properties. This review focused on the role of purinergic signaling in IRI and rejection after heart transplantation, as well as the clinical applications and prospects of purinergic signaling.<\/jats:p>","DOI":"10.3389\/fimmu.2022.826943","type":"journal-article","created":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T10:42:27Z","timestamp":1650537747000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["The Role of Purinergic Signaling in Heart Transplantation"],"prefix":"10.3389","volume":"13","author":[{"given":"Yanzhi","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianxin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1161\/CIRCULATIONAHA.117.029753","article-title":"Honoring 50 Years of Clinical Heart Transplantation in Circulation: In-Depth State-Of-the-Art Review","volume":"137","author":"Stehlik","year":"2018","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2017.07.019","article-title":"The Registry of the International Society for Heart and Lung Transplantation: Thirty-Fourth Adult Heart Transplantation Report-2017; Focus Theme: Allograft Ischemic Time","volume":"36","author":"Lund","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2021.07.015","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-Eighth Adult Heart Transplantation Report - 2021; Focus on Recipient Characteristics","volume":"40","author":"Khush","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2021.07.022","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-Fourth Pediatric Heart Transplantation Report \u2014 2021; Focus on Recipient Characteristics","volume":"40","author":"Singh","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab416","article-title":"The Stanford Experience of Heart Transplantation Over Five Decades","volume":"42","author":"Zhu","year":"2021","journal-title":"Eur Heart J"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2014.2038","article-title":"Survival Benefit of Solid-Organ Transplant in the United States","volume":"150","author":"Rana","year":"2015","journal-title":"JAMA Surg"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14499","article-title":"Maximizing Donor Allocation: A Review of UNOS Region 9 Donor Heart Turn-Downs","volume":"17","author":"Mancini","year":"2017","journal-title":"Am J Transplant"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1177\/2398212818817494","article-title":"Purine and Purinergic Receptors","volume":"2","author":"Burnstock","year":"2018","journal-title":"Brain Neurosci Adv"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/nature13085","article-title":"Nucleotide Signalling During Inflammation","volume":"509","author":"Idzko","year":"2014","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.imlet.2018.11.006","article-title":"Extracellular Nucleotides and Nucleosides as Signalling Molecules","volume":"205","author":"Giuliani","year":"2019","journal-title":"Immunol Lett"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13801","article-title":"Unlocking the Potential of Purinergic Signaling in Transplantation","volume":"16","author":"Zeiser","year":"2016","journal-title":"Am J Transplant"},{"key":"B12","article-title":"Purinergic Nerves","volume":"24","author":"Burnstock","year":"1972","journal-title":"Pharmacol Rev"},{"key":"B13","article-title":"A Basis for Distinguishing Two Types of Purinergic Receptor","volume-title":"Cell Membrane Receptors for Drugs and Hormones: A Multidisciplinary Approach","author":"Burnstock","year":"1978"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.4","article-title":"Purinergic Regulation of the Immune System","volume":"16","author":"Cekic","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3109\/10409238.2014.953627","article-title":"Enzymes Involved in Metabolism of Extracellular Nucleotides and Nucleosides: Functional Implications and Measurement of Activities","volume":"49","author":"Yegutkin","year":"2014","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s11302-012-9309-4","article-title":"Cellular Function and Molecular Structure of Ecto-Nucleotidases","volume":"8","author":"Zimmermann","year":"2012","journal-title":"Purinergic Signal"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2013.03.005","article-title":"CD39 and CD73 in Immunity and Inflammation","volume":"19","author":"Antonioli","year":"2013","journal-title":"Trends Mol Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1042\/BST0330216","article-title":"The Concentrative Nucleoside Transporter Family (SLC28): New Roles Beyond Salvage","volume":"33","author":"Aymerich","year":"2005","journal-title":"Biochem Soc Trans"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1042\/BST20160038","article-title":"The SLC28 (CNT) and SLC29 (ENT) Nucleoside Transporter Families: A 30-Year Collaborative Odyssey","volume":"44","author":"Young","year":"2016","journal-title":"Biochem Soc Trans"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000003682","article-title":"Targeting CD39 Toward Activated Platelets Reduces Systemic Inflammation and Improves Survival in Sepsis: A Preclinical Pilot Study","volume":"47","author":"Granja","year":"2019","journal-title":"Crit Care Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00285.2019","article-title":"Cell Type- and Tissue-Specific Functions of Ecto-5\u2019-Nucleotidase (CD73)","volume":"317","author":"Minor","year":"2019","journal-title":"Am J Physiol Cell Physiol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-051116-052406","article-title":"Purine Release, Metabolism, and Signaling in the Inflammatory Response","volume":"37","author":"Linden","year":"2019","journal-title":"Annu Rev Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s11302-012-9342-3","article-title":"The CD39-Adenosinergic Axis in the Pathogenesis of Renal Ischemia\u2013Reperfusion Injury","volume":"9","author":"Roberts","year":"2013","journal-title":"Purinergic Signal"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s11302-017-9596-x","article-title":"CD39-Adenosinergic Axis in Renal Pathophysiology and Therapeutics","volume":"14","author":"Kishore","year":"2018","journal-title":"Purinergic Signal"},{"key":"B25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/MOT.0000000000000484","article-title":"ATP and T-Cell-Mediated Rejection","volume":"23","author":"Castillo-Leon","year":"2018","journal-title":"Curr Opin Organ Transplant"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00430.2020","article-title":"Structural and Functional Characterization of Engineered Bifunctional Fusion Proteins of CD39 and CD73 Ectonucleotidases","volume":"320","author":"Zhong","year":"2021","journal-title":"Am J Physiol Cell Physiol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.619458","article-title":"Ectonucleotidases in Acute and Chronic Inflammation","volume":"11","author":"Giuliani","year":"2021","journal-title":"Front Pharmacol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-17-0042","article-title":"Activation of the P2Y2 Receptor Regulates Bone Cell Function by Enhancing ATP Release","volume":"233","author":"Orriss","year":"2017","journal-title":"J Endocrinol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.586831","article-title":"Alkaline Phosphatases Account for Low Plasma Levels of Inorganic Pyrophosphate in Chronic Kidney Disease","volume":"8","author":"Laurain","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M513042200","article-title":"Ectoadenylate Kinase and Plasma Membrane ATP Synthase Activities of Human Vascular Endothelial Cells*","volume":"281","author":"Quillen","year":"2006","journal-title":"J Biol Chem"},{"key":"B31","article-title":"Purinergic Receptors in the Heart","volume":"46","author":"Burnstock","year":"1980","journal-title":"Circ Res"},{"key":"B32","article-title":"International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors","volume":"53","author":"Fredholm","year":"2001","journal-title":"Pharmacol Rev"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00049.2017","article-title":"Pharmacology of Adenosine Receptors: The State of the Art","volume":"98","author":"Borea","year":"2018","journal-title":"Physiol Rev"},{"key":"B34","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/bs.ai.2017.05.006","article-title":"P2Y Receptors in Immune Response and Inflammation","volume":"136","author":"Le Duc","year":"2017","journal-title":"Adv Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15005","article-title":"Update of P2Y Receptor Pharmacology: IUPHAR Review 27","volume":"177","author":"Jacobson","year":"2020","journal-title":"Br J Pharmacol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1152\/ajpcell.00053.2020","article-title":"Purinergic Signalling, DAMPs and Inflammation","volume":"318","author":"Virgilio","year":"2020","journal-title":"Am J Physiol Cell Physiol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01633","article-title":"Purinergic Signaling in Pulmonary Inflammation","volume":"10","author":"Le","year":"2019","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8632048","article-title":"Potential Therapeutic Role of Purinergic Receptors in Cardiovascular Disease Mediated by SARS-CoV-2","volume":"2020","author":"Dos Anjos","year":"2020","journal-title":"J Immunol Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1983","article-title":"Adenosine Receptors as Therapeutic Targets","volume":"5","author":"Jacobson","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2018.02.002","article-title":"Adenosine Metabolism, Immunity and Joint Health","volume":"151","author":"Hask\u00f3","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5584871","article-title":"Adenosine A1 Receptor Deficiency Aggravates Extracellular Matrix Accumulation in Diabetic Nephropathy Through Disturbance of Peritubular Microenvironment","volume":"2021","author":"Tian","year":"2021","journal-title":"J\u00a0Diabetes Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114739","article-title":"Adenosine A1 Receptor Is Dispensable for Hepatocyte Glucose Metabolism and Insulin Sensitivity","volume":"192","author":"Jain","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.680706","article-title":"Electroacupuncture Pretreatment Prevents Cognitive Impairment Induced by Cerebral Ischemia-Reperfusion via Adenosine A1 Receptors in Rats","volume":"13","author":"Shi","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.828","article-title":"Safety and Tolerability of Neladenoson Bialanate, a Novel Oral Partial Adenosine A1 Receptor Agonist, in Patients With Chronic Heart Failure","volume":"57","author":"Voors","year":"2017","journal-title":"J\u00a0Clin Pharmacol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1681\/ASN.2014121248","article-title":"Hypoxia-Inducible Factor-2\u03b1 Limits Natural Killer T Cell Cytotoxicity in Renal Ischemia\/Reperfusion Injury","volume":"27","author":"Zhang","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1097\/NEN.0000000000000174","article-title":"Critical Contribution of Adenosine A2A Receptors in Bone Marrow-Derived Cells to White Matter Lesions Induced by Chronic Cerebral Hypoperfusion","volume":"74","author":"Ran","year":"2015","journal-title":"J Neuropathol Exp Neurol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2010.02.084","article-title":"Activation of Adenosine A2A Receptor Attenuates Inflammatory Response in a Rat Model of Small-for-Size Liver Transplantation","volume":"42","author":"Tang","year":"2010","journal-title":"Transplant Proc"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.495.2008","article-title":"Adenosine A2A Receptor Activation Reduces Infarct Size in the Isolated, Perfused Mouse Heart by Inhibiting Resident Cardiac Mast Cell Degranulation","volume":"295","author":"Rork","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2020.110051","article-title":"Harnessing Adenosine A2A Receptors as a Strategy for Suppressing the Lung Inflammation and Thrombotic Complications of COVID-19: Potential of Pentoxifylline and Dipyridamole","volume":"143","author":"DiNicolantonio","year":"2020","journal-title":"Med Hypotheses"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2021.1953217","article-title":"Hypoxia-Inducible Factor-1alpha Protects the Liver Against Ischemia-Reperfusion Injury by Regulating the A2B Adenosine Receptor","volume":"12","author":"Zhang","year":"2021","journal-title":"Bioengineered"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.588757","article-title":"Protective Effect of Adenosine A2B Receptor Agonist, BAY60-6583, Against Transient Focal Brain Ischemia in Rat","volume":"11","author":"Dettori","year":"2020","journal-title":"Front Pharmacol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2013.01.059","article-title":"Adenosine A3 Receptor Activation Attenuates Lung Ischemia-Reperfusion Injury","volume":"95","author":"Mulloy","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2018.06.042","article-title":"Infarct-Sparing Effect of Adenosine A2B Receptor Agonist Is Primarily Due to Its Action on Splenic Leukocytes Via a PI3K\/Akt\/IL-10 Pathway","volume":"232","author":"Ni","year":"2018","journal-title":"J Surg Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.663011","article-title":"Expression and Gene Regulation Network of Adenosine Receptor A2B in Lung Adenocarcinoma: A Potential Diagnostic and Prognostic Biomarker","volume":"8","author":"Sui","year":"2021","journal-title":"Front Mol Biosci"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601315","article-title":"Inhibition of Primary Colon Carcinoma Growth and Liver Metastasis by the A3 Adenosine Receptor Agonist CF101","volume":"89","author":"Ohana","year":"2003","journal-title":"Br J Cancer"},{"key":"B56","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1593\/neo.04364","article-title":"CF101, an Agonist to the A3 Adenosine Receptor, Enhances the Chemotherapeutic Effect of 5-Fluorouracil in a Colon Carcinoma Murine Model","volume":"7","author":"Bar-Yehuda","year":"2005","journal-title":"Neoplasia"},{"key":"B57","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11302-015-9493-0","article-title":"P2X Ion Channel Receptors and Inflammation","volume":"12","author":"Burnstock","year":"2016","journal-title":"Purinergic Signal"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15651","article-title":"Extracellular Nucleotide Signaling in Solid Organ Transplantation","volume":"20","author":"Yeudall","year":"2020","journal-title":"Am J Transplant"},{"key":"B59","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1152\/physrev.2001.81.2.767","article-title":"Adenosine 5\u2019-Triphosphate: A P2-Purinergic Agonist in the Myocardium","volume":"81","author":"Vassort","year":"2001","journal-title":"Physiol Rev"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1080\/14017431.2018.1552793","article-title":"Role of Pannexin and Adenosine Triphosphate (ATP) Following Myocardial Ischemia\/Reperfusion","volume":"52","author":"Kristiansen","year":"2018","journal-title":"Scand Cardiovasc J"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1159\/000051064","article-title":"P2X Receptor Immunoreactivity in Different Arteries From the Femoral, Pulmonary, Cerebral, Coronary and Renal Circulations","volume":"38","author":"Lewis","year":"2001","journal-title":"J\u00a0Vasc Res"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1007\/s11302-011-9224-0","article-title":"The P2X1 Receptor and Platelet Function","volume":"7","author":"Mahaut-Smith","year":"2011","journal-title":"Purinergic Signalling"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28492","article-title":"P2X1-Regulated IL-22 Secretion by Innate Lymphoid Cells Is Required for Efficient Liver Regeneration","volume":"63","author":"Kudira","year":"2016","journal-title":"Hepatology"},{"key":"B64","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.brainresbull.2007.07.031","article-title":"Myocardial Ischemic Nociceptive Signaling Mediated by P2X3 Receptor in Rat Stellate Ganglion Neurons","volume":"75","author":"Zhang","year":"2008","journal-title":"Brain Res Bull"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2020.10.004","article-title":"Glucokinase in Stellate Ganglia Cooperates With P2X3 Receptor to Develop Cardiac Sympathetic Neuropathy in Type 2 Diabetes Rats","volume":"165","author":"Xu","year":"2020","journal-title":"Brain Res Bull"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2020.113308","article-title":"Neuroprotective and Neuro-Rehabilitative Effects of Acute Purinergic Receptor P2X4 (P2X4R) Blockade After Ischemic Stroke","volume":"329","author":"Srivastava","year":"2020","journal-title":"Exp Neurol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2017.07.155","article-title":"Deletion of the P2X4 Receptor Is Neuroprotective Acutely, But Induces a Depressive Phenotype During Recovery From Ischemic Stroke","volume":"66","author":"Verma","year":"2017","journal-title":"Brain Behav Immun"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1172\/JCI94524","article-title":"P2X7R Mutation Disrupts the NLRP3-Mediated Th Program and Predicts Poor Cardiac Allograft Outcomes","volume":"128","author":"D\u2019Addio","year":"2018","journal-title":"J Clin Invest"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-018-0037-0","article-title":"Extracellular ATP and P2 Purinergic Signalling in the Tumour Microenvironment","volume":"18","author":"Di Virgilio","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114406","article-title":"P2Y Receptors for Extracellular Nucleotides: Contributions to Cancer Progression and Therapeutic Implications","volume":"187","author":"Woods","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1039\/d1fo00531f","article-title":"Ginsenosides Rb2 and Rd2 Isolated From Panax Notoginseng Flowers Attenuate Platelet Function Through P2Y12-Mediated cAMP\/PKA and PI3K\/Akt\/Erk1\/2 Signaling","volume":"12","author":"Zuo","year":"2021","journal-title":"Food Funct"},{"key":"B72","doi-asserted-by":"publisher","first-page":"E8572","DOI":"10.3390\/ijms21228572","article-title":"P2Y2 and P2X4 Receptors Mediate Ca2+ Mobilization in DH82 Canine Macrophage Cells","volume":"21","author":"Sophocleous","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.30564","article-title":"Involvement of P2Y Signaling in the Restoration of Glucose-Induced Insulin Exocytosis in Pancreatic \u03b2 Cells Exposed to Glucotoxicity","volume":"237","author":"Mesto","year":"2021","journal-title":"J Cell Physiol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2019.02.011","article-title":"The Role of Adenosine and P2Y Receptors Expressed by Multiple Cell Types in Pain Transmission","volume":"151","author":"Magni","year":"2019","journal-title":"Brain Res Bull"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.10.027","article-title":"The Regulation of Skin Fibrosis in Systemic Sclerosis by Extracellular ATP via P2Y2 Purinergic Receptor","volume":"139","author":"Perera","year":"2019","journal-title":"J Invest Dermatol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.phrs.2016.08.009","article-title":"Current Knowledge on the Role of P2Y Receptors in Cardioprotection Against Ischemia-Reperfusion","volume":"118","author":"Djerada","year":"2017","journal-title":"Pharmacol Res"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/nature05704","article-title":"UDP Acting at P2Y6 Receptors Is a Mediator of Microglial Phagocytosis","volume":"446","author":"Koizumi","year":"2007","journal-title":"Nature"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601520","article-title":"Efferocytosis Signaling in the Regulation of Macrophage Inflammatory Responses","volume":"198","author":"Elliott","year":"2017","journal-title":"J Immunol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1126\/science.1132559","article-title":"ATP Release Guides Neutrophil Chemotaxis Via P2Y2 A3 Receptors","volume":"314","author":"Chen","year":"2006","journal-title":"Science"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1012518","article-title":"LPS-Induced Systemic Inflammation is More Severe in P2Y12 Null Mice","volume":"95","author":"Liverani","year":"2014","journal-title":"J\u00a0Leukoc Biol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.116.307401","article-title":"P2Y12 Receptor Modulates Sepsis-Induced Inflammation","volume":"36","author":"Liverani","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114419","article-title":"The Role of P2Y Receptors in Regulating Immunity and Metabolism","volume":"187","author":"Lov\u00e1szi","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2011.07.094","article-title":"UTP Reduces Infarct Size and Improves Mice Heart Function After Myocardial Infarct via P2Y2 Receptor","volume":"82","author":"Cohen","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.2174\/1389450115666140519162133","article-title":"The Role of P2Y12 Receptor and Activated Platelets During Inflammation","volume":"15","author":"Liverani","year":"2014","journal-title":"Curr Drug Targets"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceca.2015.08.004","article-title":"Calcium Signaling and the Novel Anti-Proliferative Effect of the UTP-Sensitive P2Y11 Receptor in Rat Cardiac Myofibroblasts","volume":"58","author":"Certal","year":"2015","journal-title":"Cell Calcium"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2017.03.013","article-title":"Purinergic P2Y6 Receptors: A New Therapeutic Target of Age-Dependent Hypertension","volume":"120","author":"Sunggip","year":"2017","journal-title":"Pharmacol Res"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.684118","article-title":"Loss of Mouse P2Y6 Nucleotide Receptor Is Associated With Physiological Macrocardia and Amplified Pathological Cardiac Hypertrophy","volume":"291","author":"Clouet","year":"2016","journal-title":"J Biol Chem"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2016.0166","article-title":"Mouse P2Y4 Nucleotide Receptor Is a Negative Regulator of Cardiac Adipose-Derived Stem Cell Differentiation and Cardiac Fat Formation","volume":"26","author":"Lemaire","year":"2017","journal-title":"Stem Cells Dev"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2007.07.057","article-title":"From ATP to AZD6140: The Discovery of an Orally Active Reversible P2Y12 Receptor Antagonist for the Prevention of Thrombosis","volume":"17","author":"Springthorpe","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"B90","doi-asserted-by":"publisher","first-page":"745","DOI":"10.2165\/00003495-199754050-00006","article-title":"Clopidogrel","volume":"54","author":"Coukell","year":"1997","journal-title":"Drugs"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2017.07.016","article-title":"The Registry of the International Society for Heart and Lung Transplantation: Thirty-Fourth Adult Lung And Heart-Lung Transplantation Report-2017; Focus Theme: Allograft Ischemic Time","volume":"36","author":"Chambers","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"B92","doi-asserted-by":"crossref","DOI":"10.1051\/ject\/200941140","article-title":"Perfusion Preservation of the Donor Heart: Basic Science to Pre-Clinical","volume":"41","author":"Rivard","year":"2009","journal-title":"J Extra Corpor Technol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00018-020-03615-7","article-title":"Sterile Inflammation in Thoracic Transplantation","volume":"78","author":"Frye","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00053.2020","article-title":"Purinergic Signaling, DAMPs, and Inflammation","volume":"318","author":"Di Virgilio","year":"2020","journal-title":"Am J Physiol Cell Physiol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2019.00183","article-title":"P2X7 Interactions and Signaling \u2013 Making Head or Tail of It","volume":"12","author":"Kopp","year":"2019","journal-title":"Front Mol Neurosci"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.120.315116","article-title":"P2X7 Receptors","volume":"41","author":"Shokoples","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1161\/CIRCULATIONAHA.110.982777","article-title":"Inflammasome Activation of Cardiac Fibroblasts Is Essential for Myocardial Ischemia\/Reperfusion Injury","volume":"123","author":"Kawaguchi","year":"2011","journal-title":"Circulation"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.041611398","article-title":"Inhibition of Caspase 1 Reduces Human Myocardial Ischemic Dysfunction via Inhibition of IL-18 and IL-1beta","volume":"98","author":"Pomerantz","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201601307R","article-title":"CD73-Derived Adenosine and Tenascin-C Control Cytokine Production by Epicardium-Derived Cells Formed After Myocardial Infarction","volume":"31","author":"Hesse","year":"2017","journal-title":"FASEB J"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvt091","article-title":"The NLRP3 Inflammasome is Up-Regulated in Cardiac Fibroblasts and Mediates Myocardial Ischaemia-Reperfusion Injury","volume":"99","author":"Sandanger","year":"2013","journal-title":"Cardiovasc Res"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1177\/1074248409360356","article-title":"Pannexin-I\/P2X 7 Purinergic Receptor Channels Mediate the Release of Cardioprotectants Induced by Ischemic Pre- and Postconditioning","volume":"15","author":"Vessey","year":"2010","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00305.2011","article-title":"P2X7 Receptor Agonists Pre- and Postcondition the Heart Against Ischemia-Reperfusion Injury by Opening Pannexin-1\/P2X7 Channels","volume":"301","author":"Vessey","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11010-011-0713-9","article-title":"Ischemic Preconditioning Requires Opening of Pannexin-1\/P2X(7) Channels Not Only During Preconditioning But Again After Index Ischemia at Full Reperfusion","volume":"351","author":"Vessey","year":"2011","journal-title":"Mol Cell Biochem"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1007\/s43440-019-00046-5","article-title":"Cardioprotective Properties of the Platelet P2Y12 Receptor Inhibitor Prasugrel on Cardiac Ischemia\/Reperfusion Injury","volume":"72","author":"Dost","year":"2020","journal-title":"Pharmacol Rep"},{"key":"B105","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s00395-021-00870-y","article-title":"Translation of Experimental Cardioprotective Capability of P2Y12 Inhibitors Into Clinical Outcome in Patients With ST-Elevation Myocardial Infarction","volume":"116","author":"Hjortbak","year":"2021","journal-title":"Basic Res Cardiol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.12.071","article-title":"Superior Myocardial Protection Using \u201cPolarizing\u201d Adenosine, Lidocaine, and Mg2+ Cardioplegia in Humans","volume":"67","author":"Onorati","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10194485","article-title":"Cardioplegia Between Evolution and Revolution: From Depolarized to Polarized Cardiac Arrest in Adult Cardiac Surgery","volume":"10","author":"Francica","year":"2021","journal-title":"JCM"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2013.04.016","article-title":"A Cardioprotective Preservation Strategy Employing Ex Vivo Heart Perfusion Facilitates Successful Transplant of Donor Hearts After Cardiocirculatory Death","volume":"32","author":"Cw","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2021.07.028","article-title":"Effects of Graft Preservation Conditions on Coronary Endothelium and Cardiac Functional Recovery in a Rat Model of Donation After Circulatory Death","volume":"40","author":"M\u00e9ndez-Carmona","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13574","article-title":"Avoidance of Profound Hypothermia During Initial Reperfusion Improves the Functional Recovery of Hearts Donated After Circulatory Death","volume":"16","author":"White","year":"2016","journal-title":"Am J Transplant"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00052.2011","article-title":"Contributions of A2A and A2B Adenosine Receptors in Coronary Flow Responses in Relation to the KATP Channel Using A2B and A2A\/2B Double-Knockout Mice","volume":"301","author":"Sanjani","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.98.7.711","article-title":"A2A-Adenosine Receptor Reserve for Coronary Vasodilation","volume":"98","author":"Shryock","year":"1998","journal-title":"Circulation"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1111\/j.1549-8719.2010.00054.x","article-title":"Contribution of Adenosine A(2A) and A(2B) Receptors to Ischemic Coronary Dilation: Role of K(V) and K(ATP) Channels","volume":"17","author":"Berwick","year":"2010","journal-title":"Microcirculation"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2013.02.005","article-title":"Attenuating Myocardial Ischemia by Targeting A2B Adenosine Receptors","volume":"19","author":"Eltzschig","year":"2013","journal-title":"Trends Mol Med"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-385526-8.00006-0","article-title":"Interplay of Hypoxia and A2B Adenosine Receptors in Tissue Protection","volume":"61","author":"Koeppen","year":"2011","journal-title":"Adv Pharmacol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1993.265.5.H1471","article-title":"Inhibition of Adenosine-Mediated Coronary Vasodilation Exacerbates Myocardial Ischemia During Exercise","volume":"265","author":"Laxson","year":"1993","journal-title":"Am J Physiol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2728","article-title":"Adora2b-Elicited Per2 Stabilization Promotes a HIF-Dependent Metabolic Switch Crucial for Myocardial Adaptation to Ischemia","volume":"18","author":"Eckle","year":"2012","journal-title":"Nat Med"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2009.2644","article-title":"Endogenous Adenosine Selectively Modulates Oxidant Stress via the A1 Receptor in Ischemic Hearts","volume":"11","author":"Reichelt","year":"2009","journal-title":"Antioxid Redox Signal"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.810101","article-title":"Adenosine A3 Receptor and Cardioprotection: Enticing, Enigmatic, Elusive","volume":"118","author":"Rothermel","year":"2008","journal-title":"Circulation"},{"key":"B120","doi-asserted-by":"publisher","first-page":"e0135086","DOI":"10.1371\/journal.pone.0135086","article-title":"Extracellular Adenosine Formation by Ecto-5\u2019-Nucleotidase (CD73) Is No Essential Trigger for Early Phase Ischemic Preconditioning","volume":"10","author":"Wolff","year":"2015","journal-title":"PLoS One"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2016.10.016","article-title":"Impact of Cardiac-Specific Expression of CD39 on Myocardial Infarct Size in Mice","volume":"179","author":"Smith","year":"2017","journal-title":"Life Sci"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2012.01.002","article-title":"Transgenic Swine: Expression of Human CD39 Protects Against Myocardial Injury","volume":"52","author":"Wheeler","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"e34730","DOI":"10.1371\/journal.pone.0034730","article-title":"Resident Cardiac Immune Cells and Expression of the Ectonucleotidase Enzymes CD39 and CD73 After Ischemic Injury","volume":"7","author":"B\u00f6nner","year":"2012","journal-title":"PLoS One"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.690180","article-title":"CD39\/Ectonucleoside Triphosphate Diphosphohydrolase 1 Provides Myocardial Protection During Cardiac Ischemia\/Reperfusion Injury","volume":"116","author":"K\u00f6hler","year":"2007","journal-title":"Circulation"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx218","article-title":"Peter K. A Single-Chain Antibody-CD39 Fusion Protein Targeting Activated Platelets Protects From Cardiac Ischaemia\/Reperfusion Injury","volume":"39","author":"Ziegler","year":"2018","journal-title":"Eur Heart J"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M705268200","article-title":"Defective Metabolic Signaling in Adenylate Kinase AK1 Gene Knock-Out Hearts Compromises Post-Ischemic Coronary Reflow","volume":"282","author":"Dzeja","year":"2007","journal-title":"J Biol Chem"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00116.2002","article-title":"Adenylate Kinase AK1 Knockout Heart: Energetics and Functional Performance Under Ischemia-Reperfusion","volume":"283","author":"Pucar","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.123653","article-title":"Long-Term Heart Transplant Survival by Targeting the Ionotropic Purinergic Receptor P2X7","volume":"127","author":"Vergani","year":"2013","journal-title":"Circulation"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13808","article-title":"Graft-Infiltrating Macrophages Adopt an M2 Phenotype and Are Inhibited by Purinergic Receptor P2X7 Antagonist in Chronic Rejection","volume":"16","author":"Wu","year":"2016","journal-title":"Am J Transplant"},{"key":"B130","doi-asserted-by":"publisher","first-page":"11613","DOI":"10.1038\/s41598-019-48006-6","article-title":"Stimulation of P2Y11 Receptor Protects Human Cardiomyocytes Against Hypoxia\/Reoxygenation Injury and Involves Pkc\u03f5 Signaling Pathway","volume":"9","author":"Benoist","year":"2019","journal-title":"Sci Rep"},{"key":"B131","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.jtcvs.2018.12.014","article-title":"Stimulation of Murine P2Y11-Like Purinoreceptor Protects Against Hypoxia\/Reoxygenation Injury and Decreases Heart Graft Rejection Lesions","volume":"158","author":"Bourguignon","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200009270-00003","article-title":"Recombinant Adenoviral Mediated CD39 Gene Transfer Prolongs Cardiac Xenograft Survival","volume":"70","author":"Imai","year":"2000","journal-title":"Transplantation"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199612270-00008","article-title":"Apyrase Administration Prolongs Discordant Xenograft Survival","volume":"62","author":"Koyamada","year":"1996","journal-title":"Transplantation"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200419560","article-title":"Thromboregulatory Manifestations in Human CD39 Transgenic Mice and the Implications for Thrombotic Disease and Transplantation","volume":"113","author":"Dwyer","year":"2004","journal-title":"J Clin Invest"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.108.180059","article-title":"Ecto-5\u2019 Nucleotidase (CD73)-Mediated Adenosine Generation and Signaling in Murine Cardiac Allograft Vasculopathy","volume":"103","author":"Hasegawa","year":"2008","journal-title":"Circ Res"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.20-0154","article-title":"CD73 Expression is Critical to Therapeutic Effects of Human Endometrial Regenerative Cells in Inhibition of Cardiac Allograft Rejection in Mice","volume":"10","author":"Hu","year":"2021","journal-title":"Stem Cells Trans Med"},{"key":"B137","doi-asserted-by":"publisher","first-page":"e61828","DOI":"10.1371\/journal.pone.0061828","article-title":"Co-Culture of Neural Crest Stem Cells (NCSC) and Insulin Producing Beta-TC6 Cells Results in Cadherin Junctions and Protection Against Cytokine-Induced Beta-Cell Death","volume":"8","author":"Ngamjariyawat","year":"2013","journal-title":"PLoS One"},{"key":"B138","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3892\/mmr.2021.12159","article-title":"Carbenoxolone has the Potential to Ameliorate Acute Incision Pain in Rats","volume":"24","author":"Dong","year":"2021","journal-title":"Mol Med Rep"},{"key":"B139","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12974-018-1230-5","article-title":"Astrocytic Gap Junction Inhibition by Carbenoxolone Enhances the Protective Effects of Ischemic Preconditioning Following Cerebral Ischemia","volume":"15","author":"Ma","year":"2018","journal-title":"J Neuroinflamm"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00004.2018","article-title":"Pannexin-1 Channels on Endothelial Cells Mediate Vascular Inflammation During Lung Ischemia-Reperfusion Injury","volume":"315","author":"Sharma","year":"2018","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2012.207","article-title":"Macrophage\/monocyte Depletion by Clodronate, But Not Diphtheria Toxin, Improves Renal Ischemia\/Reperfusion Injury in Mice","volume":"82","author":"Ferenbach","year":"2012","journal-title":"Kidney Int"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1038\/srep22143","article-title":"The Macrophage-Depleting Agent Clodronate Promotes Durable Hematopoietic Chimerism and Donor-Specific Skin Allograft Tolerance in Mice","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.113.000674","article-title":"Magnetic Resonance Imaging Investigation of Macrophages in Acute Cardiac Allograft Rejection After Heart Transplantation","volume":"6","author":"Wu","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13091504","article-title":"A Recombinant Fusion Construct Between Human Serum Albumin and NTPDase CD39 Allows Anti-Inflammatory and Anti-Thrombotic Coating of Medical Devices","volume":"13","author":"Abraham","year":"2021","journal-title":"Pharmaceutics"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2001.4816","article-title":"P2y(12), a New Platelet ADP Receptor, Target of Clopidogrel","volume":"283","author":"Savi","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2017.04.002","article-title":"P2Y12 Receptor Function and Response to Cangrelor in Neonates With Cyanotic Congenital Heart Disease","volume":"2","author":"Kaza","year":"2017","journal-title":"JACC Basic Transl Sci"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2021.07.009","article-title":"Reconditioning of Circulatory Death Hearts by Ex-Vivo Machine Perfusion With a Novel HTK-N Preservation Solution","volume":"40","author":"Saemann","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezv413","article-title":"Donor Pretreatment With Adenosine Monophosphate-Activated Protein Kinase Activator Protects Cardiac Grafts From Cold Ischaemia\/Reperfusion Injury","volume":"49","author":"Yang","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezw426","article-title":"Prolonging Hypothermic Ischaemic Cardiac and Vascular Storage by Inhibiting the Activation of the Nuclear Enzyme Poly(Adenosine Diphosphate-Ribose) Polymerase","volume":"51","author":"Korkmaz-Ic\u00f6z","year":"2017","journal-title":"Eur J Cardiothorac Surg"},{"key":"B150","doi-asserted-by":"publisher","first-page":"e007954","DOI":"10.1161\/CIRCEP.120.007954","article-title":"Management of Arrhythmias After Heart Transplant: Current State and Considerations for Future Research","volume":"14","author":"Joglar","year":"2021","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.028087","article-title":"Prospective Study of Adenosine on Atrioventricular Nodal Conduction in Pediatric and Young Adult Patients After Heart Transplantation","volume":"135","author":"Flyer","year":"2017","journal-title":"Circulation"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2012.06.001","article-title":"Noninvasive Detection of Transplant Coronary Artery Disease With Contrast-Enhanced Cardiac MRI in Pediatric Cardiac Transplants","volume":"31","author":"Madani","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1007\/s00247-021-04977-1","article-title":"Feasibility and Safety of Quantitative Adenosine Stress Perfusion Cardiac Magnetic Resonance Imaging in Pediatric Heart Transplant Patients With and Without Coronary Allograft Vasculopathy","volume":"51","author":"Duran","year":"2021","journal-title":"Pediatr Radiol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1591","article-title":"PANTHEON Investigators. Safety and Efficacy of the Partial Adenosine A1 Receptor Agonist Neladenoson Bialanate in Patients With Chronic Heart Failure With Reduced Ejection Fraction: A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Trial","volume":"21","author":"Voors","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.6717","article-title":"Effect of Neladenoson Bialanate on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial","volume":"321","author":"Shah","year":"2019","journal-title":"JAMA"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2011.06.062","article-title":"Adenosine a2A Agonist Improves Lung Function During Ex-Vivo Lung Perfusion","volume":"92","author":"Emaminia","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2020.02.003","article-title":"Adenosine A2A Receptor Agonist (Regadenoson) in Human Lung Transplantation","volume":"39","author":"Lau","year":"2020","journal-title":"J\u00a0Heart Lung Transplant"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.826943\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T08:50:44Z","timestamp":1700470244000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.826943\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,21]]},"references-count":157,"alternative-id":["10.3389\/fimmu.2022.826943"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.826943","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2022,4,21]]},"article-number":"826943"}}